Services & Products

CRDMO for API

Oligos for IVD

Powering the Advancement of Oligonucleotide Therapeutics and Genomic Diagnostics

Founded in 2011, BiOligo is a specialized CRDMO partner for the oligonucleotide therapeutics and in vitro diagnostics (IVD) industries.

For oligonucleotide therapeutics partners, BiOligo supports OD- to kilogram-scale production, delivering ultra-high purity and ultra-low endotoxin specifications to biopharma companies from early discovery through clinical and commercial supply.

For IVD partners, BiOligo provides primers and probes, enzymes, and NGS reagents, supported by ultra high purity and our Sterile Oligo Synthesis Management Platform for controlled microbial background and consistent quality across molecular diagnostic applications.

BiOligo Global Network
Our Impact
OD to kg+ Production Capacity
200+ Modification
50+ Patents
3,000+ Global Customers

What do our customers say?

TESTIMONIALS

·

Chief Operating Officer

Molecular Diagnostics Solution Company, UK

Having our orders delivered in exact and consistent final yields makes batch planning so much easier! This totally avoids the trouble of order delays or re-orders for us, especially when our products require hundreds of oligos in use.

Drug Development Scientist

Oligonucleotide Therapeutics Company, USA

We were working on an intrathecal delivery project, so endotoxin was a big consideration for us. We ordered siRNA from BiOligo, and the endotoxin level came back below 0.01 EU/mg. That was a huge relief and really helped move the project forward. We really appreciated BiOligo’s support.

How can we help you?

It's our pleasure to support you.